KCT0008008尚未招募未知
Efficacy and Safety Evaluation of Advanced Vessel Sealing Device (Vi-sealer)
Bundang CHA General Hospital0 个研究点目标入组 280 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 280
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 20(Year) 至 65(Year)（—）
- 性别
- Female
入选标准
- •1. Aged 20 to 65 years
- •2. Clinically diagnosed with benign gynecologic neoplasms (eg.
- •adenomyosis, uterine fibroids, etc.)
- •3. Eligible for hysterectomy
- •4. Signing an written consent form indicating that they understand the
- •purpose of and procedures required for the study and are willing to
- •participate in the study prior to any other study-related assessments or
排除标准
- •1. Large uterus size over 16 weeks of gestational age
- •2. Cervical or intraligamentary fibroids
- •3. Severe endometriosis (stage 3 or 4)
- •4. Suspected malignancy of the uterus or adnexa
- •5. Contraindicated for the use of energy devices (such as implantable
- •cardioverter defibrillators, pacemakers)
- •6. Previous pelvic surgery = 3 times
- •7. Not suitable for laparoscopic surgery
研究者
相似试验
已完成
不适用
Evaluation of efficucy and safety of newly developed capsule endoscope and software.Small bowel diseaseJPRN-UMIN000010976Center for Diagnostic and Therapeutic Endoscopy, School of Medicine, Keio University40
已完成
4 期
A study to compare drugs Vortioxetine and Escitalopram, used for treatment of DepressioCTRI/2019/11/022030Dr Anshul Upadhyay60
尚未招募
Unknown
To know if the mouth wash prepared from certain herbal products is effective and safe to treat the gingivitisCTRI/2024/01/061413DR ZADC AMU ALIGARH
进行中（未招募）
1 期
EFFICACY AND SAFETY STUDY OF THE ANTIHISTAMINE V0114CP 2.5MG IN THE TREATMENT OF SEASONAL ALLERGIC RHINITIS. RANDOMISED, DOUBLE-BLIND, THREE ARM PARALLEL GROUP STUDY INCLUDING PLACEBO AND ACTIVE CONTROL ARM (DESLORATADINE 5 MG)The medical condition to be investigated in this study is the seasonal allergic rhinitis. The intended indication for the product is the treatment of allergic rhinitisEUCTR2008-000133-22-PLPierre Fabre Médicament900
尚未招募
不适用
Assessment of the Safety and Performance of the AB1 Electrosurgical System for Bronchoscopic Microwave Ablation of Lung Tissue in Surgical Candidates (AB1MALTISC)lung cancerlung carcinoma100386661002910710038737NL-OMON56952Creo Medical Limited10